[Elsevier] Appropriate Risk Classification and Low-Dose Rituximab May Help Prevent Acute Rejection in ABO-Compatible Living Kidney Transplantation |
|
This post will be closed automatically in 2026-07-03 23:00
Reward10points
|
| |
post
reply
points
2080
25
10.1016/s1474-4422(24)00395-8
10
Two-dimensional (2D) materials beyond graphene in cancer drug delivery, photothermal and photodynamic therapy, recent advances and challenges ahead: A review
10
Cardiopat赤a isqu谷mica: concepto, clasificaci車n, epidemiolog赤a, medidas preventivas y tratamiento no farmacol車gico
10
Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study
10
Power load forecasting and anomaly detection using a two-stage attention mechanism and deep neural networks
